Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Mablink Bioscience S.A.S.

Headquarters: Lyon, France
Website: N/A
Year Founded: 2018
Status: Acquired

BioCentury | May 14, 2024
Management Tracks

John Milad named CEO of CRISPR play ERS Genomics

Plus: Senhwa hires Jason Huang as CMO, and updates from Egle and The Jackson Laboratory
BioCentury | Oct 19, 2023
Regulation

Oct. 18 Quick Takes: FDA approves UCB’s Bimzelx and Zilbrysq

Plus: After appeal, Ardelyx wins approval of kidney therapy, and updates from Mablink, Actym, Syncona, CDER and more
BioCentury | Jun 15, 2023
Management Tracks

Kite’s Huston joins Galapagos as CFO, COO

Plus: Burgess to head BD at Cerevel, and updates from Mablink, PathAI and Berlin
BioCentury | Oct 14, 2022
Finance

Oct. 14 Quick Takes: Sofinnova Partners, Mérieux back French ADC company Mablink

Plus Enliven finds path to NASDAQ via Imara deal and updates from Reata, Travere, Fujifilm, Inotrem, Obatala
BioCentury | Mar 17, 2022
Management Tracks

Denali co-founder, COO Schuth to take on CFO role

Plus Immunic promotes Whaley to CFO and updates from Mablink, Agendia, SNIPR and more
BioCentury | Mar 2, 2022
Management Tracks

Crinetics recruits Arrowhead alum Hassard as CCO

Plus Hillhouse-backed Overland finds CTO in Xun Liu, and updates from Veracyte, Janux, Connect and more
BioCentury | Dec 7, 2021
Emerging Company Profile

Emergence: creating better ADCs for Nectin-4

German start-up raises €87M series A as it seeks to improve upon Seagen’s Padcev 
Items per page:
1 - 7 of 7